7.11
전일 마감가:
$7.21
열려 있는:
$7.19
하루 거래량:
225.03K
Relative Volume:
0.71
시가총액:
$161.13M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-7.5638
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
-1.25%
1개월 성능:
-25.86%
6개월 성능:
+1.86%
1년 성능:
+24.08%
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
XGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
XGN
Exagen Inc
|
7.11 | 163.40M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 개시 | B. Riley Securities | Buy |
| 2025-07-30 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | 개시 | Craig Hallum | Buy |
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
What New Catalysts Are Shaping the Narrative for Exagen? - Yahoo Finance
Comparing Fonar (NASDAQ:FONR) & Exagen (NASDAQ:XGN) - Defense World
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Will Exagen Inc. stock maintain dividend yield2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Why Exagen Inc. (E08A) stock stays resilientWatch List & Daily Entry Point Trade Alerts - Newser
Is Exagen Inc. (E08A) stock good for wealth creationWeekly Trend Report & Daily Chart Pattern Signals - Newser
Is Exagen Inc. (E08A) stock protected from inflationTrade Volume Report & Free Technical Confirmation Trade Alerts - Newser
How Exagen Inc. (E08A) stock correlates with oil marketsQuarterly Profit Report & Expert Approved Momentum Trade Ideas - Newser
How higher bond yields impact Exagen Inc. (E08A) stockQuarterly Earnings Summary & Safe Entry Zone Identification - Newser
Is Exagen Inc. (E08A) stock supported by strong fundamentalsWeekly Trade Review & Verified Short-Term Plans - Newser
Exagen continues to execute on re-acceleration strategy, says Canaccord - TipRanks
Is Exagen Inc E08A a good long term investmentStock Market Trends & Free Realize Exceptional Returns - earlytimes.in
Exagen price target raised to $18 from $15 at B. Riley - MSN
What Wall Street predicts for Exagen Inc. stock price2025 Volatility Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - MSN
Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India
The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):